For example, it would be of interest to know whether other pathways are involved in the anti-proliferative effect of FOXO1 and investigate what other components of the malignant phenotype are determined by FOXO1 and miRNAs in prostate cancer cells, and these issues are currently under further investigation in our laboratory. Here, FOXO1 is linked to Familial prostate cancer.